4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000020
CEO bought 43,000 shares at an average $0.02 ($827)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-19 | Purchase : show line 1 in the form | +2,000 | $0.02 | $38 | 21,870,623 | D |
| 2019-03-19 | Purchase : show line 2 in the form | +100 | $0.02 | $2 | 21,870,723 | D |
| 2019-03-19 | Purchase : show line 3 in the form | +1,900 | $0.02 | $36 | 21,872,623 | D |
| 2019-03-19 | Purchase : show line 4 in the form | +2,000 | $0.02 | $37 | 21,874,623 | D |
| 2019-03-19 | Purchase : show line 5 in the form | +10,000 | $0.02 | $197 | 21,884,623 | D |
| 2019-03-19 | Purchase : show line 6 in the form | +50 | $0.02 | $1 | 21,884,673 | D |
| 2019-03-19 | Purchase : show line 7 in the form | +950 | $0.02 | $19 | 21,885,623 | D |
| 2019-03-20 | Purchase : show line 8 in the form | +2,000 | $0.02 | $39 | 21,887,623 | D |
| Open-market purchases · 43,000 sh · avg $0.02 · $827 | ||||||
Loading xslF345X03/primary_doc.xml…